Cargando…

Escherichia coli-derived virus-like particles in vaccine development

Recombinant virus-like particle-based vaccines are composed of viral structural proteins and mimic authentic native viruses but are devoid of viral genetic materials. They are the active components in highly safe and effective vaccines for the prevention of infectious diseases. Several expression sy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Xiaofen, Wang, Xin, Zhang, Jun, Xia, Ningshao, Zhao, Qinjian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627247/ https://www.ncbi.nlm.nih.gov/pubmed/29263864 http://dx.doi.org/10.1038/s41541-017-0006-8

Ejemplares similares

Prophylactic Hepatitis E Vaccines: Antigenic Analysis and Serological Evaluation
por: Li, Yike, et al.
Publicado: (2020)

Rational design of a multi-valent human papillomavirus vaccine by capsomere-hybrid co-assembly of virus-like particles
por: Wang, Daning, et al.
Publicado: (2020)

Molecular and functional analysis of monoclonal antibodies in support of biologics development
por: Wang, Xin, et al.
Publicado: (2017)

Virus-like Particle Vaccines of Infectious Bursal Disease Virus Expressed in Escherichia coli Are Highly Immunogenic and Protect against Virulent Strain
por: Ji, Pengchao, et al.
Publicado: (2023)

Omics-guided bacterial engineering of Escherichia coli ER2566 for recombinant protein expression
por: Zhou, Lizhi, et al.
Publicado: (2022)

Truncated glycoprotein E of varicella-zoster virus is an ideal immunogen for Escherichia coli-based vaccine design
por: Chen, Tingting, et al.
Publicado: (2023)

Production of FMDV virus-like particles by a SUMO fusion protein approach in Escherichia coli
por: Lee, Chien-Der, et al.
Publicado: (2009)

Characterization of an Escherichia coli-derived triple-type chimeric vaccine against human papillomavirus types 39, 68 and 70
por: Qian, Ciying, et al.
Publicado: (2022)

Virus-like Particle Vaccines and Platforms for Vaccine Development
por: Kheirvari, Milad, et al.
Publicado: (2023)

Recent Progress on the Versatility of Virus-Like Particles
por: Qian, Ciying, et al.
Publicado: (2020)

Long-Term immunopersistence and safety of the Escherichia coli-produced HPV-16/18 bivalent vaccine in Chinese adolescent girls
por: Yao, Xingmei, et al.
Publicado: (2022)

Hepatitis E Vaccine to Prevent Morbidity and Mortality During Epidemics
por: Nelson, Kenrad E., et al.
Publicado: (2014)

Escherichia coli-Based Cell-Free Protein Synthesis for Iterative Design of Tandem-Core Virus-Like Particles
por: Colant, Noelle, et al.
Publicado: (2021)

Survival of Escherichia coli in Airborne and Settled Poultry Litter Particles
por: Nguyen, Xuan Dung, et al.
Publicado: (2022)

Self-assembly of virus-like particles of porcine circovirus type 2 capsid protein expressed from Escherichia coli
por: Yin, Shuanghui, et al.
Publicado: (2010)

Virus like particles as a platform for cancer vaccine development
por: Ong, Hui Kian, et al.
Publicado: (2017)

Virus-Like Particles and Nanoparticles for Vaccine Development against HCMV
por: Perotti, Michela, et al.
Publicado: (2019)

Intestinal Pathogenic Escherichia coli: Insights for Vaccine Development
por: Rojas-Lopez, Maricarmen, et al.
Publicado: (2018)

Capsid destabilization and epitope alterations of human papillomavirus 18 in the presence of thimerosal
por: Huang, Xiaofen, et al.
Publicado: (2021)

Virus-Like Particle Systems for Vaccine Development against Viruses in the Flaviviridae Family
por: Wong, Shu Hui, et al.
Publicado: (2019)

Production of virus-like particles for vaccines
por: Fuenmayor, J., et al.
Publicado: (2017)

Virus-Like Particle and Nanoparticle Vaccines
por: Kanekiyo, M., et al.
Publicado: (2017)

Incorporation of membrane-anchored flagellin or Escherichia coli heat-labile enterotoxin B subunit enhances the immunogenicity of rabies virus-like particles in mice and dogs
por: Qi, Yinglin, et al.
Publicado: (2015)

A COVID-19 mRNA vaccine encoding SARS-CoV-2 virus-like particles induces a strong antiviral-like immune response in mice
por: Lu, Jing, et al.
Publicado: (2020)

N-Glycosylation Modification of Plant-Derived Virus-Like Particles: An Application in Vaccines
por: Kim, Hyun-Soon, et al.
Publicado: (2014)

A novel vaccine candidate based on chimeric virus-like particle displaying multiple conserved epitope peptides induced neutralizing antibodies against EBV infection
por: Zhang, Xiao, et al.
Publicado: (2020)

Recent Advances in the Development of Virus-Like Particle-Based Flavivirus Vaccines
por: Zhang, Naru, et al.
Publicado: (2020)

Development of virus-like particles with inbuilt immunostimulatory properties as vaccine candidates
por: Collett, Simon, et al.
Publicado: (2023)

A human monoclonal antibody against HPV16 recognizes an immunodominant and neutralizing epitope partially overlapping with that of H16.V5
por: Xia, Lin, et al.
Publicado: (2016)

From cholera to enterotoxigenic Escherichia coli (ETEC) vaccine development
por: Svennerholm, Ann-Mari
Publicado: (2011)

Trigger factor assisted self-assembly of canine parvovirus VP2 protein into virus-like particles in Escherichia coli with high immunogenicity
por: Nan, Liangliang, et al.
Publicado: (2018)

Disassembly and reassembly of human papillomavirus virus-like particles produces more virion-like antibody reactivity
por: Zhao, Qinjian, et al.
Publicado: (2012)

Vaccine Potential of Nipah Virus-Like Particles
por: Walpita, Pramila, et al.
Publicado: (2011)

Special Issue “Virus-Like Particle Vaccines”
por: Vogel, Monique, et al.
Publicado: (2020)

Virus-like Particle Vaccines for Norovirus Gastroenteritis
por: Chen, Qiang
Publicado: (2013)

Virus-Like Particles as an Instrument of Vaccine Production
por: Syomin, B. V., et al.
Publicado: (2019)

Virus‐like particles for vaccination against cancer
por: Mohsen, Mona O., et al.
Publicado: (2019)

Production of glycoprotein vaccines in Escherichia coli
por: Ihssen, Julian, et al.
Publicado: (2010)

Engineering for an HPV 9-valent vaccine candidate using genomic constitutive over-expression and low lipopolysaccharide levels in Escherichia coli cells
por: Wang, Kaihang, et al.
Publicado: (2021)

Preclinical Development and Production of Virus-Like Particles As Vaccine Candidates for Hepatitis C
por: Masavuli, Makutiro Ghislain, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_oocefajgro25f9cm7ee3e605hp